Blueprint Medicines (BPMC) Earnings
|
Expand Research on BPMC
| Next EPS Date | N/A | EPS Growth Rate | +100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +33.6% | Revenue Growth Rate | -100.0% *Last Qtr. |
| Average % Move 1-Wk after EPS | +0.8% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
7/30/25  |
Q225 | N/A | -$0.44 | N/A | N/A | $171.52M | = | N/A | N/A | ||
| 5/1/25 | Q125 | $0.01 | -$0.49 | +$0.50 | $149.41M | $156.83M | = |  | | Details | |
| 2/13/25 | Q424 | -$0.79 | -$0.70 | -$0.09 | $144.1M | $146.14M | = | | | Details | |
| 10/30/24 | Q324 | -$0.89 | -$0.96 | +$0.07 | $128.18M | $127.56M | = | | | Details | |
| 8/1/24 | Q224 | -$0.80 | -$1.29 | +$0.49 | $138.2M | $103.57M | = | | | Details | |
| 5/2/24 | Q124 | $1.40 | -$1.67 | +$3.07 | $96.12M | $80.89M | = | | | Details | |
| 2/15/24 | Q423 | -$1.82 | -$2.04 | +$0.22 | $71.95M | $66.92M | = | | | Details | |
| 10/26/23 | Q323 | -$2.20 | -$2.38 | +$0.18 | $56.56M | $50.66M | N/A | | | Details |
